• Sulfo-NHS-Biotin for Surface-to-Secretome Assays

  2026-08-15

  Sulfo-NHS-Biotin provides a water-compatible route to covalently tag accessible primary amines on proteins and intact cell surfaces. This article explains how to use that surface-defined signal as an orthogonal layer alongside SEC-seq, while avoiding the common mistake of treating surface labeling as a direct readout of secretion.

• X-Gal Workflows for Cloning and Reporter Validation

  2026-08-14

  Turn lacZα-based clone selection into a faster, more interpretable molecular cloning workflow with practical X-Gal setup, controls, and troubleshooting. The same strategy can support construct-quality checks for olfactory receptor studies, while clearly separating cloning readouts from biological activity measurements.

• Halazone Workflows for Water and Nerve Research

  2026-08-14

  Halazone combines rapid oxidative water disinfection with a distinctive neurophysiology use-case: perturbing sodium-current inactivation in myelinated nerve fibers. This guide converts those findings into practical preparation, assay, controls, and troubleshooting workflows for microbiology and electrophysiology laboratories.

• EdU Imaging Kits (Cy3) for S-Phase Assays

  2026-08-13

  EdU Imaging Kits (Cy3) deliver denaturation-free visualization of DNA replication for microscopy and flow cytometry. This practical guide connects assay design with glioblastoma perturbation studies, quantitative analysis, and troubleshooting.

• Taltirelin acetate Workflows for Neuroscience

  2026-08-13

  Taltirelin acetate combines long-acting TRH-receptor signaling with practical utility across sleep, neurodegeneration, itch, and formulation studies. This guide translates the strongest in vivo evidence into executable workflows, assay choices, and troubleshooting strategies.

• Saquinavir: A Membrane-Aware Assay Strategy

  2026-08-12

  Saquinavir is a clinically important HIV protease inhibitor whose assay interpretation benefits from membrane-aware experimental design. This guide connects HIV protease enzymatic pathway studies with IAM LC and LEKC permeability models while clarifying what each method can—and cannot—prove.

• GDC-0941: A Mechanism-First Assay Guide

  2026-08-12

  GDC-0941 is a selective PI3K inhibitor for dissecting PI3K/Akt signaling beyond simple viability measurements. This guide connects pathway pharmacology with assay design, EMT interpretation, and the latest evidence on CDK4/6–BET crosstalk in pancreatic cancer.

• Anisomycin Workflows for JNK Apoptosis Research

  2026-08-11

  Use Anisomycin as a time-resolved JNK agonist for dissecting stress signaling, apoptosis, and pathway-dependent cell vulnerability. This workflow also shows how to use it carefully as a hypothesis-testing perturbation alongside the neuroligin 1 mechanisms that sustain social memory.

• Tobramycin Workflows for Gram-Negative Research

  2026-08-11

  Build reproducible Tobramycin susceptibility, comparator, and resistance experiments with water-based preparation and reference-aligned microdilution parameters. This practical guide connects mechanism, assay design, troubleshooting, and comparative interpretation without turning in-vitro findings into clinical claims.

• Ceftolozane/Tazobactam: Evidence and Research Design

  2026-08-10

  The reference review explains why ceftolozane/tazobactam was developed as an antipseudomonal cephalosporin and β-lactamase inhibitor combination, emphasizing PBP targeting, activity against resistant Gram-negative pathogens, and pharmacokinetic/pharmacodynamic exposure targets. Its practical value lies in connecting microbiology, resistance mechanisms, dosing, renal elimination, clinical-trial evidence, and safety into a framework for interpreting new antibacterial therapies.

• GLP-1 (9-36) Amide: GLP-1R Antagonist Guide

  2026-08-09

  GLP-1 (9-36) amide is a research-grade glucagon-like peptide-1 receptor antagonist for controlled studies of GLP-1 receptor signaling. Product documentation identifies it as a lyophilized peptide with a molecular weight of 3089.44 g/mol, while peer-reviewed FRET work demonstrates why antagonist controls are important when evaluating ligand selectivity at GLP-1R.

• Tamoxifen Workflows for CreER and Cell Research

  2026-08-08

  Tamoxifen supports both inducible CreER-mediated gene knockout and mechanistically controlled cell assays, but its estrogen-receptor and protein kinase C activities require careful controls. This workflow translates lineage-tracing findings from bone research into practical preparation, assay, optimization, and troubleshooting strategies.

• Meropenem Workflows for Resistance Research

  2026-08-07

  Build reproducible antibacterial assays, Gram-negative infection models, and carbapenem-resistance workflows with Meropenem (SKU A5124). This guide connects PBP-targeted activity with plasmid transmission research, while providing practical preparation, optimization, and troubleshooting strategies.

• β-Elemene: Applied Protocols for Adipogenesis & Neuroprotect

  2026-08-07

  β-Elemene uniquely bridges adipogenesis inhibition and neuroprotection through dual modulation of the AMPK and PI3K/AKT/mTOR signaling pathways. This guide translates the latest reference study and cross-domain findings into actionable experimental workflows, troubleshooting insights, and optimization strategies for advanced metabolic and neural research.

• Cholecystokinin Octapeptide Antagonism of Electroacupuncture

  2026-08-06

  This study reveals that cholecystokinin octapeptide (CCK-8) antagonizes electroacupuncture-induced analgesia in rats and plays a role in the development of analgesic tolerance. The findings clarify how endogenous CCK-8 modulates opioid-mediated pain relief, informing the design of neuropharmacological and behavioral research protocols.

16154 records 1/1077 page Next 12345 下5页 Last page